Aortic Aneurysm and Dissection Clinical Trial
Official title:
Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(Graft Study)
To explore the effect and prognosis of endovascular interventional therapy in high-risk patients with aortic arch dissection and aneurysm
The WeFlow-Tribranch Aortic Arch Stent Graft System first in man study is a prospective, multi-center, single arm trial, which will enroll a total of 20 patients. The goal of this study is to evaluate the safety and efficacy of WeFlow-Tribranch Aortic Arch Stent Graft System in the treatment of patients with aortic arch dissection and aneurysm. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05434481 -
MITAORTA - Role of Mitochondrial Dynamic in Aneurysm and Dissection of Ascending Thoracic Aorta
|
N/A | |
| Active, not recruiting |
NCT03861741 -
A Study to Evaluate the Feasibility of Screening Relatives of Patients Affected by Non-Syndromic Thoracic Aortic Diseases
|
N/A | |
| Not yet recruiting |
NCT04431336 -
Young Patient With Aortic Dissection or Aneurysm: A Prospective Observational Cohort Study
|
||
| Recruiting |
NCT06336213 -
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
|
N/A |